As of 2024-12-14, the Relative Valuation of Viracta Therapeutics Inc (VIRX) is (20.21) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.19 USD, the upside of Viracta Therapeutics Inc based on Relative Valuation is -10746.3%.
The range of the Relative Valuation is (21.00) - (21.35) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.1x - 24.4x | 17.5x |
| Forward P/E multiples | 19.3x - 19.6x | 19.6x |
| Fair Price | (21.00) - (21.35) | (20.21) |
| Upside | -11165.2% - -11348.9% | -10746.3% |
| Date | P/E |
| 2024-11-29 | -0.13 |
| 2024-11-27 | -0.14 |
| 2024-11-26 | -0.13 |
| 2024-11-25 | -0.14 |
| 2024-11-22 | -0.15 |
| 2024-11-21 | -0.14 |
| 2024-11-20 | -0.14 |
| 2024-11-19 | -0.14 |
| 2024-11-18 | -0.14 |
| 2024-11-15 | -0.14 |
| 2024-11-14 | -0.14 |
| 2024-11-13 | -0.14 |
| 2024-11-12 | -0.16 |
| 2024-11-11 | -0.17 |
| 2024-11-08 | -0.17 |
| 2024-11-07 | -0.17 |
| 2024-11-06 | -0.17 |
| 2024-11-05 | -0.18 |
| 2024-11-04 | -0.18 |
| 2024-11-01 | -0.18 |
| 2024-10-31 | -0.19 |
| 2024-10-30 | -0.19 |
| 2024-10-29 | -0.20 |
| 2024-10-28 | -0.21 |
| 2024-10-25 | -0.24 |
| 2024-10-24 | -0.22 |
| 2024-10-23 | -0.22 |
| 2024-10-22 | -0.22 |
| 2024-10-21 | -0.22 |
| 2024-10-18 | -0.21 |
| 2024-10-17 | -0.20 |
| 2024-10-16 | -0.21 |
| 2024-10-15 | -0.20 |
| 2024-10-14 | -0.21 |
| 2024-10-11 | -0.21 |
| 2024-10-10 | -0.21 |
| 2024-10-09 | -0.21 |
| 2024-10-08 | -0.22 |
| 2024-10-07 | -0.21 |
| 2024-10-04 | -0.21 |
| 2024-10-03 | -0.21 |
| 2024-10-02 | -0.21 |
| 2024-10-01 | -0.21 |
| 2024-09-30 | -0.21 |
| 2024-09-27 | -0.20 |
| 2024-09-26 | -0.20 |
| 2024-09-25 | -0.21 |
| 2024-09-24 | -0.21 |
| 2024-09-23 | -0.20 |
| 2024-09-20 | -0.21 |